• Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa

  2026-05-21

  This study systematically deciphers how iron oxide nanoparticle size and PEGylation dictate their uptake by distinct liver cell populations. The findings challenge longstanding models of hepatic clearance, revealing new design principles for nanomedicine targeting and safety.

• Aclacinomycin A: Applied Workflows for DNA Damage & Apoptosi

  2026-05-21

  Aclacinomycin A (Aclarubicin) stands out as a dual topoisomerase inhibitor and apoptosis inducer, enabling precision in dissecting DNA damage and cell death mechanisms in cancer research. This article delivers protocol optimizations, troubleshooting insights, and translational guidance rooted in recent nucleolar DNA damage findings and APExBIO’s rigorously validated supply.

• 2X HyperFusion™ High-Fidelity Master Mix: Reliable PCR for C

  2026-05-20

  This article provides an evidence-based, scenario-driven analysis of how the 2X HyperFusion™ High-Fidelity Master Mix (SKU K1039) addresses core reproducibility and fidelity challenges in cell viability, proliferation, and cytotoxicity assays. Through real-world laboratory Q&A, it demonstrates how this master mix’s advanced polymerase chemistry empowers biomedical researchers with high accuracy DNA amplification, blunt-end PCR products, and proven workflow reliability.

• Tobramycin: Optimizing Gram-Negative Research Workflows

  2026-05-20

  Tobramycin, a water-soluble aminoglycoside antibiotic, enables high-precision studies of Gram-negative bacterial mechanisms and resistance. This article delivers actionable protocols, troubleshooting strategies, and comparative insights to help elevate microbiology research with APExBIO’s high-purity Tobramycin.

• 2'3'-cGAMP (Sodium Salt): REC8-Driven Precision in Innate Im

  2026-05-19

  Explore how 2'3'-cGAMP (sodium salt) enables advanced insights into REC8-mediated STING pathway regulation and robust type I interferon induction. This article uniquely bridges molecular mechanisms with practical research strategies for immunology and antiviral assay design.

• KU-55933 and Next-Gen ATM Inhibition: Personalized Disease M

  2026-05-19

  Explore the unique role of KU-55933, a potent ATM kinase inhibitor, in advancing DNA damage response research and personalized iPSC-based disease modeling. Gain deep insight into assay design, metabolic endpoints, and translational implications for cancer research.

• Endothelial STING-JAK1 Axis: Tumor Vessel Normalization and

  2026-05-18

  This article reviews recent findings that endothelial STING-JAK1 interactions drive tumor vasculature normalization and enhance antitumor immunity by selectively promoting type I interferon signaling and CD8+ T cell infiltration. The research clarifies cell type–specific mechanisms in cGAS-STING pathway activation and outlines implications for immunotherapy design.

• Oxaliplatin Workflows: Advanced Protocols in Cancer Chemothe

  2026-05-18

  Harness the full potential of Oxaliplatin with evidence-driven workflows that enhance apoptosis induction and overcome chemoresistance in preclinical models. Discover step-by-step protocols, synergistic strategies, and troubleshooting guidance for reliable, translational cancer research.

• 4-Hydroxytamoxifen: Technical Guidance for Lab Research Work

  2026-05-17

  4-Hydroxytamoxifen (SKU B6167) provides researchers with a high-purity, DMSO-soluble estrogen receptor modulator suitable for breast and prostate cancer research, apoptosis assays, and cardiac myocyte studies requiring precise modulation of estrogen receptor activity. It is not compatible with aqueous or ethanol-based protocols and demands strict handling and storage to maintain reagent integrity.

• ATRX Loss Sensitizes High-Grade Glioma Cells to RTK Inhibito

  2026-05-16

  This study reveals that ATRX-deficient high-grade glioma cells display heightened sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings support integrating ATRX status into the design and interpretation of clinical trials for glioma therapies targeting these pathways.

• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-05-15

  This study uncovers how the WNT5a/GSK3/β-catenin pathway regulates adipogenesis in skeletal muscle fibro/adipogenic progenitors (FAPs), limiting pathological fat infiltration in muscle tissue. The findings provide mechanistic insight into muscle regeneration and highlight therapeutic targets for myopathies.

• Protein A/G Magnetic Co-IP/IP Kit: Streamlining Protein Comp

  2026-05-15

  The Protein A/G Magnetic Co-IP/IP Kit empowers researchers with rapid, reproducible isolation of protein complexes, supporting high-fidelity protein-protein interaction analysis and antibody purification. Its magnetic bead-based workflow minimizes degradation and enables direct downstream applications such as SDS-PAGE and mass spectrometry.

• Chenodeoxycholic Acid in FXR Signaling: Protocols & Optimiza

  2026-05-14

  Chenodeoxycholic Acid (CDCA) is transforming nuclear receptor signaling studies through robust activation of FXR, enabling precise dissection of cholesterol metabolism and acute kidney injury pathways. This guide details experimental workflows, troubleshooting strategies, and protocol parameters for maximizing CDCA’s impact in metabolic and renal research.

• CD28-ARS2 Axis Drives PKM2 Splicing for CD8+ T Cell Flexibil

  2026-05-14

  This study uncovers how the CD28-ARS2 signaling axis in CD8+ T cells orchestrates alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform crucial for metabolic flexibility and antitumor function. The findings reveal a previously unrecognized mechanism linking co-stimulatory signaling to immunometabolic reprogramming, with implications for cancer immunotherapy.

• Influenza Hemagglutinin (HA) Peptide: Precision in Exosome P

  2026-05-13

  Explore the critical role of Influenza Hemagglutinin (HA) Peptide in advanced exosome pathway analysis and protein interaction studies. This article reveals how high-purity HA tag peptide enables precise assay design, connecting new mechanistic insights with robust molecular biology workflows.

16681 records 1/1113 page Next 12345 下5页 Last page